HCA (HCA)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$134.92B
EV / Sales1.73
EV / EBITDA8.52
EV / Operating Cash Flow12.13
EV / Free Cash Flow22.50

Return Metrics (TTM)

Return on Equity (ROE)-112.87%
Return on Assets (ROA)11.30%
Return on Invested Capital (ROIC)19.41%
Return on Capital Employed (ROCE)29.17%

Yield Metrics

Earnings Yield7.62%
Free Cash Flow Yield6.88%

Balance Sheet Strength

Net Debt / EBITDA3.02
Current Ratio0.78
Working Capital-$4.19B
Tangible Asset Value-$13.80B
Net Current Asset Value-$48.72B

Working Capital Efficiency

Days Sales Outstanding57.46
Days Payables Outstanding31.03
Operating Cycle (Days)68.31
Cash Conversion Cycle37.28

Capital Allocation

CapEx / Revenue6.57%
CapEx / Operating Cash Flow46.09%
R&D / Revenue0.00%
SG&A / Revenue21.24%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin41.50%
Operating Margin15.83%
Net Profit Margin8.97%

Solvency

Debt / Equity-8.33
Quick Ratio0.73
Cash Ratio0.06

Per Share

Revenue / Share$327.68
FCF / Share$33.34
PE Ratio16.31